from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1417/-

LFCtreatmentdescriptionclass of inhibitor

-0.712

Amikacinug/mL Amikacintranslation

-0.775

Cap5-10ug/mL Capreomycintranslation

-0.998

Rox10-50 ug/mL Roxithromycintranslation

-0.537

SM2-5 ug/mL Streptomycintranslation

-1.443

Tet5-10 ug/mL Tetracyclinetranslation

0.644

Rif0.2-5ug/mL Rifampicintranscription

0.404

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.331

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.898

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.055

CPZ10-50 ug/mL Chlorpromazinerespiration

1.064

Clofazimine10-13 ug/mL Clofaziminerespiration

0.133

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.018

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.192

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.171

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.097

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.687

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.081

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.841

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.154

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.202

KCN5-20 ug/mL Potassium cyaniderespiration

-0.765

NaN30.2-2 mM Sodium aziderespiration

0.002

Nigericin50 uM Nigericinrespiration

0.763

TRC10-150 ug/mL Triclosanrespiration

0.367

TRZ10-25 ug/mL Thioridazinerespiration

-0.719

Valinomycin0.5-10 uM Valinomycinrespiration

-2.412

ZnSO42 mM ZnSO4respiration

-0.036

menadione6-10 ug/mL Menadionerespiration

0.896

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.007

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.768

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.401

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.484

NRP_1Non-replicating persistence stage 1dosRassociated

-0.495

Amp0.2mg/mL AmpicillincellWall

-0.364

Cephalexin20-100 ug/mL CephalexincellWall

-0.303

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.276

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.021

EMB10-20 ug/mL EthambutolcellWall

-0.821

Eta12-40 ug/mL EthionamidecellWall

-0.543

INH0.2-0.4 ug/mL IsoniazidcellWall

0.071

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.182

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.102

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.438

BZA0.12 mg/mL BenzamidearomaticAmides

-0.475

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.440

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.198

H2O24 mM hydrogen peroxideDNAdamaging

0.177

Levo10 ug/mL LevofloxacinDNAdamaging

-0.774

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.788

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.223

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.603

UVUV-irradiationDNAdamaging

0.795

ARP41-4 ug/mL Antitubercular compound ARP4?

0.423

Antimycin12.5-50 ug/mL Antimycin A?

-0.396

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.437

PA_110-50 ug/mL Antitubercular compound PA-1?

1.137

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.283

PA8240.2-2 ug/mL PA-824?

1.459

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.377

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.027

Verapamil50 uM Verapamil?

-0.044

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.721

methoxatin10-20 ug/mL Methoxatin?